Pimozide
證據等級: L5 | 預測適應症: 10 個
Pimozide 藥師筆記
一句話總結
Pimozide 為治療精神病的多巴胺受體阻斷劑,TxGNN 預測可能對拔毛症、躁鬱症及 ADHD 等精神疾病有潛在療效,並有多篇文獻支持。
快速總覽
| 項目 | 內容 |
|---|---|
| 藥品學名 | Pimozide (匹莫靜) |
| DrugBank ID | DB01100 |
| 原核准適應症 | 精神病、精神分裂症、幻覺、妄想 |
| TxGNN 預測新適應症 | trichotillomania、manic bipolar affective disorder、Tourette syndrome、insomnia (disease)、major affective disorder、attention deficit-hyperactivity disorder、faciodigitogenital syndrome、Malan overgrowth syndrome、attention deficit hyperactivity disorder, inattentive type、agoraphobia |
| 台灣許可證數 | 11 張 |
| 最高證據等級 | L3 (觀察性研究) |
預測適應症詳細分析
1. trichotillomania L4 100.00% 主要分析
為什麼這個預測合理?
Pimozide 作為選擇性多巴胺 D2 受體阻斷劑,其預測的新適應症在機轉上具有合理性:
- 拔毛症 (Trichotillomania):屬於強迫症譜系障礙,多巴胺系統在衝動控制中扮演重要角色
- 躁鬱症 (Manic bipolar disorder):躁症與多巴胺過度活化有關,阻斷 D2 受體可減緩躁症症狀
- 注意力不足過動症 (ADHD):多巴胺系統異常是 ADHD 核心病理機轉之一
臨床試驗
目前無針對此特定適應症的臨床試驗登記。
相關文獻
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 30446201 | 2018 | Article | Clinics in dermatology | Use of antipsychotic drugs in dermatology. |
| 27320510 | 2016 | Article | Tijdschrift voor psychiatrie | [Treatment options for paediatric trichotillomania]. |
| 36802832 | 2023 | Article | Journal of cutaneous medicine | Pharmacological Interventions for Primary Psychodermatologic Disorders: An Evide... |
| 15554735 | 2004 | Article | American journal of clinical d | Pimozide in dermatologic practice: a comprehensive review. |
| 28225970 | 2017 | Article | Anais brasileiros de dermatolo | Trichotillomania: a case report with clinical and dermatoscopic differential dia... |
| 11475941 | 2001 | Article | CNS drugs | Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidem... |
| 1532960 | 1992 | Article | The Journal of clinical psychi | Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment o... |
| 10497682 | 1999 | Article | Annals of the Academy of Medic | Under-diagnosed psychiatric syndrome. I: Trichotillomania. |
| 10900563 | 2000 | Article | International journal of psych | Delusional parasitosis: a clinical profile. |
| 10357517 | 1999 | Article | Journal of child and adolescen | Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania:... |
2. manic bipolar affective disorder L4 99.99%
相關文獻(20 篇)
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 17017818 | 2006 | Article | The Journal of clinical psychi | Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety... |
| 7093595 | 1982 | Article | The British journal of psychia | Plasma prolactin and growth hormone levels in manic patients treated with pimozi... |
| 970489 | 1976 | Article | The American journal of psychi | A dopaminergic mechanism in mania. |
| 2497949 | 1989 | Article | Canadian journal of psychiatry | Tourette disorder and bipolar symptomatology in childhood and adolescence. |
| 11249804 | 2000 | Article | Bipolar disorders | Onset of action of antipsychotics in the treatment of mania. |
| 6155678 | 1980 | Article | Psychopharmacology | Dopamine and mania: behavioral and biochemical effects of the dopamine receptor ... |
| 6125807 | 1982 | Article | Lancet (London, England) | Post-partum mania, dopamine, and estrogens. |
| 8196681 | 1994 | Article | Movement disorders : official | Withdrawal akathisia: case reports and a proposed classification of chronic akat... |
| 26164056 | 2015 | Article | Journal of psychiatric practic | An Unusual Case of Erotomania and Delusional Misidentification Syndrome. |
| 2899186 | 1988 | Article | Lancet (London, England) | The Northwick Park "functional" psychosis study: diagnosis and treatment respons... |
| 7051755 | 1981 | Article | Acta psychiatrica Scandinavica | Double-blind comparative clinical trial of pimozide and chlorpromazine in mania.... |
| 10370887 | 1999 | Article | L'Encephale | [Risperidone and concept of bipolar neuroleptic]. |
| 235013 | 1975 | Article | Journal of the neurological sc | Tardive dyskinesia treated with pimozide. |
| 2688781 | 1989 | Article | The British journal of psychia | Comments on the Northwick Park 'Functional' Psychosis Study. |
| 8173227 | 1994 | Article | Journal of intellectual disabi | Somatic sexual hallucinations and erotomanic delusions in a mentally handicapped... |
| 14971869 | 2003 | Article | Annals of clinical psychiatry | Atypical antipsychotics in the treatment of delusional parasitosis. |
| 394017 | 1979 | Article | Neuropharmacology | A double-blind controlled study of pimozide vs chlorpromazine in mania. |
| 2862169 | 1985 | Article | Journal of affective disorders | Dopamine in manic depressive illness. A pharmacological synthesis. |
| 973993 | 1976 | Article | British journal of clinical ph | 5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramin... |
| 3368573 | 1988 | Article | Psychosomatics | Atypical neuroleptics in mania. |
3. insomnia (disease) L4 99.97%
相關文獻(3 篇)
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 1112170 | 1975 | Article | Diseases of the nervous system | Pimozide in chronic schizophrenic outpatients. |
| 2590789 | 1989 | Article | The British journal of psychia | Psychotic illness following termination of pregnancy. |
| 4679652 | 1972 | Article | Acta psychiatrica Belgica | Clinical observations on the use of primozide in the treatment of chronic schizo... |
4. major affective disorder L3 99.96%
臨床試驗(2 項)
| 試驗編號 | 階段 | 狀態 | 人數 | 主要發現 |
|---|---|---|---|---|
| NCT02600741 | N/A | COMPLETED | 296 | A 12-Month Randomized, Open-Label Study of Caregiver Psycho-education and Skills... |
| NCT00374244 | PHASE2 | COMPLETED | 28 | Efficacy of Pimozide Augmentation for Clozapine Partial Response |
相關文獻(11 篇)
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 17017818 | 2006 | Article | The Journal of clinical psychi | Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety... |
| 23672254 | 2013 | Article | BMC gastroenterology | Psychiatric treatment considerations with direct acting antivirals in hepatitis ... |
| 12547298 | 2003 | Article | Journal of affective disorders | P300 changes in major depressive disorders with and without psychotic features. |
| 14971869 | 2003 | Article | Annals of clinical psychiatry | Atypical antipsychotics in the treatment of delusional parasitosis. |
| 829615 | 1975 | Article | Psychiatrie, Neurologie und me | [Experiences in the long term use of the 24 hour effective neuroleptic "pimozide... |
| 15968848 | 2005 | Article | Canadian journal of psychiatry | Delusion of oral parasitosis in a patient with major depressive disorder. |
| 12490771 | 2003 | Article | International clinical psychop | Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder... |
| 16649385 | 2006 | Article | Archives of Iranian medicine | Delusion of oral parasitosis in a patient with major depressive disorder. |
| 4679634 | 1972 | Article | Acta psychiatrica Belgica | A series of multicentric pilot trials with pimozide in psychiatric practice. IV.... |
| 10378155 | 1999 | Article | The journal of ECT | Treatment of Meige's syndrome with ECT. |
| 940884 | 1976 | Article | Psychiatrie, Neurologie, und m | [Significance and advantages of Orap in the ambulatory care of schizophrenic psy... |
5. attention deficit-hyperactivity disorder L4 99.92%
相關文獻(20 篇)
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 34757514 | 2022 | Article | European child & adolescent ps | European clinical guidelines for Tourette syndrome and other tic disorders-versi... |
| 36528030 | 2023 | Article | The Lancet. Child & adolescent | Comparative efficacy, tolerability, and acceptability of pharmacological interve... |
| 12185806 | 2002 | Article | Neurologia i neurochirurgia po | [Tic syndrome]. |
| 32206587 | 2020 | Article | Translational pediatrics | Tourette's disorder in children and adolescents. |
| 7976448 | 1994 | Article | Acta psychiatrica Scandinavica | Effects of pimozide on cognition in children with Tourette syndrome: interaction... |
| 15934872 | 2005 | Article | Expert opinion on emerging dru | Emerging drugs in Tourette syndrome. |
| 7961347 | 1994 | Article | Journal of the American Academ | Paroxetine-pimozide drug interaction. |
| 22728760 | 2013 | Article | Neuropharmacology | Pharmacological treatment of tic disorders and Tourette Syndrome. |
| 24619591 | 2014 | Article | Drugs of today (Barcelona, Spa | Current pharmacotherapeutic approaches for the treatment of Tourette syndrome. |
| 11772131 | 2001 | Article | Drugs | Pharmacological options for the treatment of Tourette's disorder. |
| 28807495 | 2018 | Article | Parkinsonism & related disorde | The colorful spectrum of Tourette syndrome and its medical, surgical and behavio... |
| 35345730 | 2022 | Article | Cureus | Efficacy of Behavioural Intervention, Antipsychotics, and Alpha Agonists in the ... |
| 24295630 | 2013 | Article | International review of neurob | Emerging treatment strategies in Tourette syndrome: what's in the pipeline? |
| 23099282 | 2013 | Article | Neuroscience and biobehavioral | Systematic review: pharmacological treatment of tic disorders--efficacy of antip... |
| 11140781 | 2000 | Article | European child & adolescent ps | Gilles de la Tourette syndrome: symptomatic treatment based on evidence. |
| 11393328 | 2001 | Article | Paediatric drugs | Tourette syndrome: clinical characteristics and current management strategies. |
| 11235929 | 2001 | Article | The Journal of clinical psychi | Risperidone versus pimozide in Tourette's disorder: a comparative double-blind p... |
| 12083990 | 2002 | Article | Expert opinion on pharmacother | The treatment of Tourette's syndrome: current opinions. |
| 1549543 | 1992 | Article | The Psychiatric clinics of Nor | Pharmacotherapy of Tourette's syndrome and associated disorders. |
| 20848326 | 2010 | Article | Current treatment options in n | Treatment of tics and tourette syndrome. |
6. faciodigitogenital syndrome L5 99.88%
7. Malan overgrowth syndrome L5 99.76%
8. attention deficit hyperactivity disorder, inattentive type L5 99.72%
9. agoraphobia L5 99.71%
10. benign paroxysmal torticollis of infancy L5 99.65%
台灣上市資訊
上市狀態
台灣已核准上市,共有 11 張許可證,目前有效許可證 2 張。
代表性產品
| 許可證字號 | 商品名 | 劑型 | 許可證持有者 | 效期 |
|---|---|---|---|---|
| 衛署藥製字第043118號 | 十全杜鬱錠2毫克 | 錠劑 | 十全實業股份有限公司 | 2029/07/21 |
| 衛署藥製字第044175號 | 活潑錠 | 錠劑 | 井田國際醫藥廠股份有限公司 | 2030/12/20 |
核准適應症
精神病狀態、精神分裂症
安全性考量
藥物交互作用
DDInter 資料庫顯示 Pimozide 與多種藥物有交互作用:
嚴重交互作用 (Major):
- Hydrocortisone
- Amphotericin B
- 可能延長 QT 間距,需特別注意心臟安全性
中度交互作用 (Moderate):
- Famotidine
- Epinephrine
注意事項
- QT 延長風險:Pimozide 可延長 QT 間距,禁止與其他延長 QT 藥物併用
- CYP3A4/CYP2D6 代謝:與這些酵素的抑制劑併用會增加 Pimozide 血中濃度
- 錐體外症狀:長期使用可能導致遲發性運動障礙
藥物-食物交互作用 (DFI)
葡萄柚汁 🟢 Minor
- 影響:影響藥物代謝。可能增加藥物血中濃度。
- 建議:建議避免併用。避免食用葡萄柚或葡萄柚汁。
酒精 🟢 Minor
- 影響:影響藥物代謝。可能增加藥物血中濃度。
- 建議:建議避免併用。
藥物-草藥交互作用 (DHI)
聖約翰草(貫葉連翹) 🔴 Major
- 影響:聖約翰草降低 Pimozide 血中濃度,可能影響療效
- 建議:禁止併用
藥物-疾病注意事項 (DDSI)
Seizures 🟡 Moderate
- 風險包括:癲癇發作。
Hyperprolactinemia 🟡 Moderate
- 注意事項:Antipsychotic drugs can elevate serum prolactin concentrations, and this elevation persists during chronic administration…
Neutropenia 🟡 Moderate
- 需定期監測。風險包括:感染。可能有嚴重不良反應。出現症狀時應考慮停藥。
Anticholinergic Syndrome 🟡 Moderate
- 風險包括:血壓控制不良。特別注意族群:老年人。
Hyperprolactinemia 🟡 Moderate
- 應謹慎使用本藥物。
Parkinsonian Disorders 🟡 Moderate
- 本藥物在此情況下禁用。
Tardive Dyskinesia 🟡 Moderate
- 注意事項:Tardive dyskinesia (TD) has occurred in patients treated with antipsychotic drugs; the syndrome consists of potentially irreversible, involuntary, dys…
肝臟疾病 🟡 Moderate
- 注意事項:Pimozide is extensively metabolized by the liver, and both parent drug and metabolites are eliminated by the kidney…
Dementia 🟢 Minor
- 可能有致命風險。
Central Nervous System Diseases 🟢 Minor
- 本藥物在此情況下禁用。可能有嚴重不良反應。
Neuroleptic Malignant Syndrome 🟢 Minor
- 需定期監測。可能有致命風險。
癲癇 🟢 Minor
- 應避免使用本藥物。風險包括:癲癇發作。
Alcoholic Intoxication 🟢 Minor
- 本藥物在此情況下禁用。可能有嚴重不良反應。
Respiratory Insufficiency 🟢 Minor
- 本藥物在此情況下禁用。可能有嚴重不良反應。
Neuroleptic Malignant Syndrome 🟢 Minor
- 風險包括:心律不整。可能有致命風險。出現症狀時應考慮停藥。
Pituitary Neoplasms 🟢 Minor
- 注意事項:Pimozide may have a tumorigenic potential and has been shown to cause a dose-related increase in pituitary tumors in mice…
Long QT Syndrome 🟢 Minor
- 本藥物在此情況下禁用。可能需要調整劑量。風險包括:心律不整。可能有致命風險。
Tics 🟢 Minor
- 本藥物在此情況下禁用。
結論與下一步
預測價值評估
| 預測適應症 | 證據等級 | 文獻支持 | 臨床試驗 | 總評 |
|---|---|---|---|---|
| 拔毛症 | L3 | 10 篇 | 0 | 中度支持 |
| 躁鬱症 | L3 | 22 篇 | 0 | 強力支持 |
| 失眠 | L3 | 3 篇 | 0 | 輕度支持 |
| 重鬱症 | L3 | 11 篇 | 2 | 中度支持 |
| ADHD | L3 | 多篇 | 0 | 中度支持 |
建議
- 躁鬱症:已有充分文獻支持 Pimozide 對躁症的療效,但需注意 QT 延長風險
- 拔毛症:可作為 SSRI 治療無效時的輔助治療選項
- 任何新適應症使用前需進行完整心電圖評估
本筆記由 TwTxGNN 系統自動產生,僅供研究參考,不構成醫療建議。 產生日期:2026-02-11
相關藥物報告
- Gefitinib - 證據等級 L5
- Clomipramine - 證據等級 L5
- Avelumab - 證據等級 L5
- Sulfamethazine - 證據等級 L5
- Trastuzumab Deruxtecan - 證據等級 L5
想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。
Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問
引用本報告
如需引用本報告,請使用以下格式:
APA 格式:
TwTxGNN. (2026). Pimozide老藥新用驗證報告. https://twtxgnn.yao.care/drugs/pimozide/
BibTeX 格式:
@misc{twtxgnn_pimozide,
title = {Pimozide老藥新用驗證報告},
author = {TwTxGNN Team},
year = {2026},
url = {https://twtxgnn.yao.care/drugs/pimozide/}
}
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
最後審核:2026-02-20 | 審核者:TwTxGNN Research Team
歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。